Pheochromocytoma and Paraganglioma
Hartmut P.H. Neumann, M.D., William F. Young, Jr., M.D., and Charis Eng, M.D., Ph.D.
N Engl J Med 2019; 381:552-565
DOI: 10.1056/NEJMra1806651
Plasma Steroid Profiles in Subclinical Compared With Overt Adrenal Cushing Syndrome
Jimmy Masjkur et al
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 10, October 2019, Pages 4331–4340
https://doi.org/10.1210/jc.2018-02349
Immune check point inhibitors-induced hypophysitis Frédérique Albarel1,2, Frédéric Castinetti1,2 and Thierry Brue1,2
European Journal of Endocrinology (2019) 181, R107–R118
https://doi.org/10.1530/EJE-19-0169
Pathogenesis and Diagnosis of Growth Hormone Deficiency in Adults.
Melmed S.
N Engl J Med. 2019 Jun 27;380(26):2551-2562.
http://doi.org/10.1056/NEJMra1817346
Nonneuroendocrine Neoplasms of the Pituitary Region.
Kaltsas GA, Kolomodi D, Randeva H, Grossman A
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3108-3123.
http://doi.org/10.1210/jc.2018-01871
Diagnosis and Management of Anabolic Androgenic Steroid Use
Diagnosis and Management of Anabolic Androgenic Steroid Use
Bradley D Anawalt
The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 7, July 2019, Pages 2490–2500
https://doi.org/10.1210/jc.2018-01882
Comentarios recientes